Navigation Links
Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model
Date:4/8/2008

Research To Be Presented at American Association of Immunologists Meeting

SOUTH SAN FRANCISCO, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its oral Syk kinase inhibitor, R788, may be a useful treatment for type 1 diabetes mellitus, according to research being presented at the American Association of Immunologists meeting in San Diego, California on April 8, 2008. Using Rigel's R788, researchers from the Department of Medicine at Columbia University Medical Center have shown that blocking Syk kinase in a well-established murine model of type 1 diabetes, delayed the onset of diabetes and prolonged survival. A reduction in the production of insulin-specific autoantibodies, an early event in type 1 diabetes pathogenesis, was also observed.

"Inhibition of the Syk kinase has the potential to reduce both autoantibody production and disarm its pathogenic consequences," said Raphael Clynes M.D., Ph.D., assistant professor in Medicine and Microbiology at Columbia University's College of Physician's and Surgeons. "In diabetes, autoantibodies against islet cells appear before the actual onset of disease providing the opportunity to intervene and disable these early events prior to immune destruction of the insulin-producing cells in the pancreas. The protection we see in these mouse models suggests that pharmacologic blockade of Syk with R788 may provide a good therapeutic strategy to treat and potentially prevent the onset or advancement of type 1 diabetes," he added.

Type 1 Diabetes and R788

According to the Juvenile Diabetes Research Foundation, type 1 diabetes, also called juvenile diabetes or insulin-dependent diabetes, occurs when the body's immune syst
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume
2. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
3. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
4. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
5. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
6. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
7. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
8. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
9. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
10. Newly Approved HIV Drug Shows Great Promise
11. Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... that it acquired Bionik Laboratories, Inc., a ... sale to qualified accredited investors of units consisting of ... of approximately $6.2 million. Shares of the Company,s common ... Markets under the symbol "DWTPD" until FINRA,s approval of ...
(Date:2/27/2015)... , Feb. 27, 2015  Two mass ... in applications as their effectiveness is established, ... Information.  Kalorama Information says that while mass ... most powerful tool in proteomic biomarker discovery ... through its traditional techniques has struggled to ...
(Date:2/26/2015)... February 27, 2015 RnRMarketResearch.com ... market research report to its store. This report ... therapeutic pipeline. The report "Corneal Ulcers - Pipeline ... therapeutic development for Corneal Ulcers. Corneal Ulcers are ... bacterial infections, viral infections & fungal infections. The ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... Ill., Feb. 8, 2011 Sysmex America, Inc. ... Service Agreement with PeaceHealth, a not-for-profit integrated healthcare ... group clinics and laboratories located in Alaska, Washington ... the agreement ensures either the installation of a ...
... MedShape Solutions, Inc., the industry ... announced the introduction and first human clinical use ... fixation device that simplifies and improves soft tissue ... surgery. After receiving 510(k) clearance from the U.S. ...
Cached Medicine Technology:PeaceHealth Standardizes Hematology Operations With Sysmex 2PeaceHealth Standardizes Hematology Operations With Sysmex 3MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction 2MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction 3
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... March 01, 2015 Heart diseases are ... 10 percent of urban adult population and 5 percent ... heart diseases and 20-30 percent of them require specialized ... ailments and coronary vascular diseases (CVD). , A division ... new market research report titled “Indian Coronary Stent Market ...
(Date:2/28/2015)... The Heart Fit Clinic started doing External Counterpulsation ... The Heart Fit Clinic is also selling the machines ... The goal is to scale the business to help ... buy External Counterpulsation machines can be difficult process. ... process and achieve the desired results. , The ...
(Date:2/28/2015)... February 28, 2015 Vancouver personal injury lawyers ... claims are affected by time limits. They stated that in ... person’s claim or even nullify it. Many a time, delays ... a client’s rights under BC law. As a result, experts ... by accidents should consult a personal injury lawyer in order ...
(Date:2/28/2015)... The Mesothelioma Applied Research Foundation (Meso ... Symposium on Malignant Mesothelioma on Monday, March 2. The ... Bethesda in Bethesda, Maryland. The following award recipients will ... the mission to cure mesothelioma. , The Klaus Brauch ... Miriam Ratner. Miriam runs the Meso Foundation’s monthly spousal ...
Breaking Medicine News(10 mins):Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4
... came to St. Louis Children,s Hospital in the summer of ... pressure in his lungs. Washington University physicians and surgeons ... fast to save his life. They collaborated to make several ... use of an artificial lung in a toddler. Their ...
... THURSDAY, June 16 (HealthDay News) -- No long-term decrease in ... officers from the New York Police Department,s Emergency Services Unit ... Trade Center, according to a new study. Researchers analyzed ... who responded to the attack and found that most had ...
... HealthDay Reporter , THURSDAY, June 16 (HealthDay News) -- The ... popular diabetes drug Actos (pioglitazone) may increase the risk of ... The agency,s warning comes five days after Germany and France ... in a class of drugs called thiazolidinediones, the only other ...
... University of Texas Health Science Center at Houston (UTHealth) could ... produce the type of fat ringing the waists of millions. ... Cell Stem Cell . The scientists have developed ... day could aid in the delivery of drugs that slow ...
... 16 (HealthDay News) -- Researchers have pinpointed the brain regions ... one of the most fundamental aspects of self-awareness. The ... of the brain that create a unified view of the ... body, according to the study published online June 16 in ...
... Kathleen Doheny HealthDay Reporter , THURSDAY, June 16 ... grades in high school and the beginning years of college, ... as they adopt more traditional sleeping schedules, a change occurs. ... Peszka, an associate professor of psychology at Hendrix College in ...
Cached Medicine News:Health News:Washington University surgeons successfully use artificial lung in toddler 2Health News:Washington University surgeons successfully use artificial lung in toddler 3Health News:Washington University surgeons successfully use artificial lung in toddler 4Health News:Lung Health of Police Responders From 9/11 Called 'Encouraging' 2Health News:Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA 2Health News:Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA 3Health News:New stem cell research could aid in battle against bulging waistlines 2Health News:Scientists Pinpoint Parts of Brain That Help People Recognize Themselves 2Health News:Night Owls' Poor Sleep Habits Can Hurt Grades 2Health News:Night Owls' Poor Sleep Habits Can Hurt Grades 3
... Tri-Active is the result of DEKA ... combination of three different methods capable ... your skin. This treatment is designed ... cellulite through the combined action of ...
... Smartepil II Plus is the latest evolution ... fast, safe and reliable system for epilation ... preset protocols in its modern software, Smartepil ... vascular treatments in full respect of the ...
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
Medicine Products: